Ming Hu Han
Affiliation: Mount Sinai School of Medicine
- Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disordersMing Hu Han
Department of Pharmacology and Systems Therapeutics, Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY, USA
Neuropharmacology 62:89-100. 2012..This article is part of a Special Issue entitled 'Anxiety and Depression'...
- Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylationPamela J Kennedy
Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Nat Neurosci 16:434-40. 2013..Our findings suggest a new mechanism by which prolonged and selective HDAC inhibition can alter behavioral and molecular adaptations to cocaine and inform the development of therapeutics for cocaine addiction...
- Rapid regulation of depression-related behaviours by control of midbrain dopamine neuronsDipesh Chaudhury
Department of Pharmacology and Systems Therapeutics, Friedman Brain Institute, Mount Sinai School of Medicine, New York, New York 10029, USA
Nature 493:532-6. 2013..Overall, these studies reveal novel firing-pattern- and neural-circuit-specific mechanisms of depression...
- HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activityMitsumasa Kurita
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
Nat Neurosci 15:1245-54. 2012..These observations support the view of HDAC2 as a promising new target for schizophrenia treatment...